We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
- Authors
Julius, Stevo; Kjeldsen, Sverre E; Weber, Michael; Brunner, Hans R; Ekman, Steffan; Hansson, Lennart; Hua, Tsushung; Laragh, John; McInnes, Gordon T; Mitchell, Lada; Plat, Francis; Schork, Anthony; Smith, Beverly; Zanchetti, Alberto; VALUE trial group
- Abstract
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial was designed to test the hypothesis that for the same blood-pressure control, valsartan would reduce cardiac morbidity and mortality more than amlodipine in hypertensive patients at high cardiovascular risk.
- Publication
Lancet (London, England), 2004, Vol 363, Issue 9426, p2022
- ISSN
1474-547X
- Publication type
Journal Article
- DOI
10.1016/S0140-6736(04)16451-9